ArticleCureus2025
Incidental Atrial Myxoma in the Shadow of COVID-19: Coincidence or an Emerging Pattern?
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary cardiac tumours are a rare entity, and atrial myxomas are a benign subtype usually found in the left atrium. They can present with a wide array of symptoms ranging from cardiac complications to systemic emboli. On the contrary, they can also manifest silently and are detected incidentally, as in this case of an 83-year-old female patient. New lung changes on an X-ray done as a part of an infection screen ultimately led to the diagnosis of an atrial myxoma confirmed by a transthoracic echocardiogram (TTE) and a transoesophageal echocardiogram (TOE). The patient was commenced on anticoagulation and was referred for cardiac surgery. Notably, she had suffered a COVID-19 infection recently, which may have acted as a catalyst in the formation of the tumour. Although a direct causal relationship cannot be established, the literature suggests that COVID-19 infection may lead to chronic inflammation, immune dysregulation, endothelial dysfunction, and other direct viral effects on tissues, all of which could potentially contribute to tumour formation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.